KRUS vs VRTX · rev $282.8M vs P/E 30, rev $3.33B
Kura Sushi USA Inc (KRUS) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Kura Sushi USA Inc (KRUS) is a restaurants company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported KRUS revenue for 2025-08-31 was $282.8M. Net income was -$1.9M. KRUS currently screens at market cap $987.6M.
Latest reported VRTX revenue for 2026-06-30 was $3.33B. Net income was $1.10B. Revenue was up 11.6% from 2026-03-31 to 2026-06-30. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
KRUS currently screens at market cap $987.6M. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the KRUS and VRTX stock pages for the full models.
Not investment advice.